{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:56:27Z","timestamp":1757778987017},"reference-count":33,"publisher":"Japanese Pharmacological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1254\/jphs.08144fp","type":"journal-article","created":{"date-parts":[[2008,9,25]],"date-time":"2008-09-25T05:50:48Z","timestamp":1222321848000},"page":"56-62","source":"Crossref","is-referenced-by-count":12,"title":["Arterial Baroreflex Dysfunction Fails to Mimic Parkinson\u2019s Disease in Rats"],"prefix":"10.1254","volume":"108","author":[{"given":"Jian-Guang","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Ming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Guo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding-Feng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Miao CY, Cai GJ, Tao X, Xie HH, Su DF. Greater hypertrophy in right than left ventricles is associated with pulmonary vasculopathy in sinoaortic-denervated Wistar-Kyoto rats. Clin Exp Pharmacol Physiol. 2004;31:450–455.","DOI":"10.1111\/j.1440-1681.2004.04023.x"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2006.04375.x"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2006.04414.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Norman RA Jr, Coleman TG, Dent AC. Continuous monitoring of arterial pressure indicates sinoaortic denervated rats are not hypertensive. Hypertension. 1981;3:119–125.","DOI":"10.1161\/01.HYP.3.1.119"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11144-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Shen W, Gill RM, Zhang JP, Jones BD, Corbly AK, Steinberg MI. Sodium channel enhancer restores baroreflex sensitivity in conscious dogs with heart failure. Am J Physiol Heart Circ Physiol. 2005;288:H1508–H1514.","DOI":"10.1152\/ajpheart.00337.2004"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.106.480061"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Shen FM, Guan YF, Xie HH, Su DF. Arterial baroreflex function determines the survival time in lipopolysaccharide-induced shock in rats. Shock. 2004;21:556–560.","DOI":"10.1097\/01.shk.0000126647.51109.5c"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Shu H, Ying-Ming W, Xu LP, Miao CY, Su DF. Increased susceptibility of ventricular arrhythmias to aconitine in anaesthetized rats is attributed to the inhibition of baroreflex. Clin Exp Pharmacol Physiol. 2004;31:249–253.","DOI":"10.1111\/j.1440-1681.2004.03988.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Cai GJ, Miao CY, Xie HH, Lu LH, Su DF. Arterial baroreflex dysfunction promotes atherosclerosis in rats. Atherosclerosis. 2005;183:41–47.","DOI":"10.1016\/j.atherosclerosis.2005.03.037"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Singer C, Weiner WJ, Sanchez-Ramos JR. Autonomic dysfunction in men with Parkinson’s disease. Eur Neurol. 1992;32:134–140.","DOI":"10.1159\/000116810"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Zesiewicz TA, Baker MJ, Wahba M, Hauser RA. Autonomic nervous system dysfunction in Parkinson’s disease. Curr Treat Options Neurol. 2003;5:149–160.","DOI":"10.1007\/s11940-003-0005-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Oka H, Yoshioka M, Onouchi K, Morita M, Mochio S, Suzuki M, et al. Characteristics of orthostatic hypotension in Parkinson’s disease. Brain. 2007;130:2425–2432.","DOI":"10.1093\/brain\/awm174"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Goldstein DS. Cardiac denervation in patients with Parkinson disease. Cleve Clin J Med. 2007;74 Suppl 1:91–94.","DOI":"10.3949\/ccjm.74.Suppl_1.S91"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Goldstein DS, Sharabi Y, Karp BI, Bentho O, Saleem A, Pacak K, et al. Cardiac sympathetic denervation preceding motor signs in Parkinson disease. Clin Auton Res. 2007;17:118–121.","DOI":"10.1007\/s10286-007-0396-1"},{"key":"16","unstructured":"16 Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed. New York: Academic Press; 1998."},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00277-W"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90516-K"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Sherer TB, Betarbet R, Greenamyre JT. Chronic subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol. 2003;179:9–16.","DOI":"10.1006\/exnr.2002.8072"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Alam M, Mayerhofer A, Schmidt WJ. The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA. Behav Brain Res. 2004;151:117–124.","DOI":"10.1016\/j.bbr.2003.08.014"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Srinivasan J, Schmidt WJ. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson’s disease. Behav Brain Res. 2004;151:191–199.","DOI":"10.1016\/j.bbr.2003.08.016"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0050789"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2007.04626.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Zhang W, Liu AJ, Yiming W, Liu JG, Shen FM, Su DF. Pressor and non-pressor effects of sodium loading on stroke in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2008;35:83–88.","DOI":"10.1111\/j.1440-1681.2007.04746.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Alexander N, Nakahara D, Ozaki N, Kaneda N, Sasaoka T, Iwata N, et al. Striatal dopamine release and metabolism in sinoaortic-denervated rats by in vivo microdialysis. Am J Physiol. 1988;254:396–399.","DOI":"10.1152\/ajpregu.1988.254.2.R396"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1038\/42166"},{"key":"27","unstructured":"27 Wooten GF. Neurochemistry and neuropharmacology of Parkinson’s disease. In: Watts RL, editor. Movement disorders: neurologic principles and practice. New York: McGraw-Hill; 1997."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Sherer TB, Betarbet R, Greenamyre JT. Environment, mitochondria, and Parkinson’s disease. Neuroscientist. 2002;8:192–197.","DOI":"10.1177\/1073858402008003004"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1038\/81834"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Carman LS, Gage FH, Shults CW. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res. 1991;553:275–283.","DOI":"10.1016\/0006-8993(91)90835-J"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(95)11489-J"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Goldstein DS, Eldadah BA, Holmes C, Pechnik S, Moak J, Saleem A, et al. Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension. 2005;46:1333–1339.","DOI":"10.1161\/01.HYP.0000188052.69549.e4"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Goldstein DS, Imrich R, Peckham E, Holmes C, Lopez G, Crews C, et al. Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation. Neurology. 2007;69:1580–1584.","DOI":"10.1212\/01.wnl.0000268696.57912.64"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T15:05:11Z","timestamp":1621436711000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/108\/1\/108_08144FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.08144fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}